Contact Information: CONTACT: Amanda Zuniga 919-433-0210
New Lifecycle Management Guidebook Provides Pharma Product Managers wIth Strategic Answers
| Source: Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwire - January 8, 2008) - Cutting Edge Information has
just published its new lifecycle management (LCM) guidebook for
pharmaceutical product managers. The guidebook directs brand teams to
implement a host of LCM strategies during development, after launch and
through patent expiration.
The report, "Pharma Brand Optimization: Lifecycle Management Strategy"
explores options for brand teams to extend their drugs' values on the
market (http://www.PharmaLifecycleManagement.com). With strategies to
expand revenue streams, protect drug patents and reach new target
audiences, the report is an ideal tool for all product managers to keep on
their bookshelves.
The study finds that the decrease in new blockbuster discoveries, as well
as a decrease in FDA approvals for new chemical entities has caused
pharmaceutical companies to shift strategy and maximize the value of their
current assets. To achieve greater value per drug, pharmaceutical
companies are increasingly establishing dedicated lifecycle management
teams either at the brand team or therapeutic area level. The study found
that 36% of participants even established a centralized LCM team to oversee
activities for all products.
"Lifecycle management is no easy task," said Amanda Zuniga, senior research
analyst and lead author of the report. "But LCM has evolved into a vital
strategic opportunity for drug companies, especially as the industry enters
into a new phase where generics will be eroding huge revenue streams in the
next two years."
"A Guidebook to Pharma Brand Optimization: Lifecycle Management Strategy"
(http://www.PharmaLifecycleManagement.com) examines 19 LCM strategies,
including implementation timelines, costs and return-on-investment
analysis. Furthermore, each strategy profile includes detailed case
studies showcasing real-life uses for each tactic. The study also
includes benchmarking data on pharmaceutical companies' lifecycle
management structures, funding, processes, and strategies. It guides
readers through a drug's lifecycle stages, offering insights and
recommendations on the most common lifecycle management strategies for each
time period. The guidebook is designed to streamline companies' LCM
strategies and processes as products move from development to market and
patent expiration.
Download a free summary of "A Guidebook to Pharma Brand Optimization:
Lifecycle Management Strategy" or purchase the report at
http://www.cuttingedgeinfo.com/pharmalifecyclemanagement/index_PH108.htm#body.